AAOMS issues opioid prescribing recommendations

ROSEMONT, Ill. – In response to the nationwide opioid epidemic, the American Association of Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations today that urge ibuprofen – rather than opioids – to be used as a first-line therapy to manage a patient’s acute and post-surgical pain. Recognizing the value and importance of the doctor-patient relationship,… Read more »

JOMS facial cellulitis study: Efforts should focus on early treatment

ROSEMONT, Ill. – Public health efforts regarding facial cellulitis – a sometimes dangerous infection of the skin – should focus on early treatment of the condition, according to a new scientific study. Researchers analyzed two years of national records of almost 75,000 adult patients who were hospitalized for facial cellulitis to try to determine factors… Read more »

AAOMS conference focuses on anesthesia patient safety

ROSEMONT, Ill. – To examine patient safety as it relates to anesthesia, 100 doctors representing a variety of dental and anesthesia specialties gathered at the first-ever Anesthesia Patient Safety Conference sponsored by the American Association of Oral and Maxillofacial Surgeons (AAOMS) Download Press Release.

Oral Health supplement featured in national publication

Oral Health, a 12-page supplement published by Mediaplanet, appeared in the March 23, 2017, issue of USA Today distributed in Chicago, Los Angeles, New York, Seattle, South Florida and Washington/Baltimore. The article “Understanding the Wisdom Behind Extracting Wisdom Teeth” by AAOMS President Dr. Douglas Fain is featured in the supplement. Download Press Release.

April is Oral Cancer Awareness Month

Rosemont, IL (April 1, 2017) – Every hour, 24-hours-a-day, 365-days-a-year, someone dies of oral or oropharyngeal cancer (cancer of the mouth and upper throat). Yet, if oral cancer is detected and treated early, treatment-related health problems are reduced and survival rates may increase. Download Press Release.

AAOMS journal: Botox helps manage Sjögren’s Syndrome salivary gland inflammation

December 20, 2016, Rosemont, Ill. – Researchers have found another potential medical use for botulinum toxin, commercially known as Botox, when they injected the drug into the inflamed salivary glands of a patient suffering from Sjögren’s Syndrome, an autoimmune disorder affecting nearly 4 million Americans. Download Press Release.